Evidence map›Paper›PMID 35834500›Full record

ArticlePloS one2022

Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.

Jessica Pinto-Ramirez, Andrea Garcia-Lopez, Sergio Salcedo-Herrera, Nasly Patino-Jaramillo, Juan Garcia-Lopez, Jefferson Barbosa-Salinas, Sergio Riveros-Enriquez, Gilma Hernandez-Herrera, Fernando Giron-Luque

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. SupervisedWorld journal of transplantation · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jessica Pinto-RamirezDepartment of Transplant Nephrology, Colombiana de Trasplantes, Bogotá, Colombia.ORCID 0000-0002-9537-7489
Andrea Garcia-LopezDepartment of Transplant Research, Colombiana de Trasplantes, Bogotá, Colombia.ORCID 0000-0002-3940-1413
Sergio Salcedo-HerreraDepartment of Transplant Nephrology, Colombiana de Trasplantes, Bogotá, Colombia.
Nasly Patino-JaramilloDepartment of Transplant Research, Colombiana de Trasplantes, Bogotá, Colombia.
Juan Garcia-LopezDepartmento of Technology and Informatics, Colombiana de Trasplantes, Bogotá, Colombia.
Jefferson Barbosa-SalinasDepartmento of Technology and Informatics, Colombiana de Trasplantes, Bogotá, Colombia.
Sergio Riveros-EnriquezDepartmento of Technology and Informatics, Colombiana de Trasplantes, Bogotá, Colombia.
Gilma Hernandez-HerreraPostgraduate Program in Epidemiology, Universidad del Rosario - Universidad CES, Bogotá-Medellín, Colombia.
Fernando Giron-LuqueDepartment of Transplant Surgery, Colombiana de Trasplantes, Bogotá, Colombia.
Fundación Neumológica Colombiana · COColombiana de TrasplantesClínica CES · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKidney transplantation is the best therapeutical option for CKD patients. Graft loss risk factors are usually estimated with the cox method. Competing risk analysis could be useful to determine the impact of different events affecting graft survival, the occurrence of an outcome of interest can be precluded by another. We aimed to determine the risk factors for graft loss in the presence of mortality as a competing event.

methodsA retrospective cohort of 1454 kidney transplant recipients who were transplanted between July 1, 2008, to May 31, 2019, in Colombiana de Trasplantes, were analyzed to determine risk factors of graft loss and mortality at 5 years post-transplantation. Kidney and patient survival probabilities were estimated by the competing risk analysis. The Fine and Gray method was used to fit a multivariable model for each outcome. Three variable selection methods were compared, and the bootstrapping technique was used for internal validation as split method for resample. The performance of the final model was assessed calculating the prediction error, brier score, c-index and calibration plot.

resultsGraft loss occurred in 169 patients (11.6%) and death in 137 (9.4%). Cumulative incidence for graft loss and death was 15.8% and 13.8% respectively. In a multivariable analysis, we found that BKV nephropathy, serum creatinine and increased number of renal biopsies were significant risk factors for graft loss. On the other hand, recipient age, acute cellular rejection, CMV disease were risk factors for death, and recipients with living donor had better survival compared to deceased-donor transplant and coronary stent. The c-index were 0.6 and 0.72 for graft loss and death model respectively.

conclusionWe developed two prediction models for graft loss and death 5 years post-transplantation by a unique transplant program in Colombia. Using a competing risk multivariable analysis, we were able to identify 3 significant risk factors for graft loss and 5 significant risk factors for death. This contributes to have a better understanding of risk factors for graft loss in a Latin-American population. The predictive performance of the models was mild.

Indexed as

Kidney TransplantationGraft RejectionGraft SurvivalHumansRetrospective StudiesRisk AssessmentRisk FactorsTransplant RecipientsTreatment Outcome

Identifiers

PMID35834500
PMCPMC9282472
OpenAlexW4285389453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.